AHMED, Syed Sohail,LONDEI, Marco,WRIGHT, Timothy,GERGELY, Peter
申请号：
AU2013209344
公开号：
AU2013209344A1
申请日:
2013.07.26
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
#$%^&*AU2013209344A120130815.pdf#####H:\fmt\Interwoven\NRPortbl\DCC\FMT\53484I8_I.DOC-25/07/2013 ABSTRACT The use of an SiP receptor modulator of the formula (Ia) or (Tb) wherein the meaning of the different residues is that indicated in claim 1, in the preparation of a medicament for preventing, inhibiting or treating an inflammatory condition selected from polymyositis, dermatomyositis and nerve-muscle diseases e.g. muscular dystrophies and inclusion body myositis.
